Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 2501 | Cord Tissue | Allogeneic – Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 56,9 |
| 2502 | Cord Tissue | Allogeneic – Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 63,7 |
| 2503 | Cord Tissue | Allogeneic – Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 49,9 |
| 2504 | Cord Tissue | Allogeneic – Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 58 |
| 2505 | Cord Tissue | Allogeneic – Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 61,4 |
| 2506 | Cord Tissue | Allogeneic – Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 60,2 |
| 2507 | Cord Tissue | Allogeneic – Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 50,8 |
| 2508 | Cord Tissue | Allogeneic – Unrelated | Graft Versus Host Disease | Hematology | 2020 | Experimental Therapy | Portugal | 18 |
| 2509 | Cord Tissue | Allogeneic – Unrelated | Graft Versus Host Disease; Transplantation Failure | Hematology | 2020 | Experimental Therapy | Poland | 2,9 |
| 2510 | Cord Tissue | Allogeneic – Unrelated | Guillain-Barré Syndrome | Neurology | 2020 | Experimental Therapy | Poland | 43,5 |
| 2511 | Cord Tissue | Allogeneic – Unrelated | Head Injury | Neurology | 2020 | Experimental Therapy | Poland | 16,3 |
| 2512 | Cord Tissue | Allogeneic – Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2020 | Experimental Therapy | Poland | 2,11 |
| 2513 | Cord Tissue | Allogeneic – Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2020 | Experimental Therapy | Poland | 5,4 |
| 2514 | Cord Tissue | Allogeneic – Unrelated | Hypoxic Encephalopathy; Drug-Resistant Epilepsy | Neurology | 2020 | Experimental Therapy | Poland | 20,9 |
| 2515 | Cord Tissue | Allogeneic – Unrelated | Limb Ulceration | Dermatology | 2020 | Experimental Therapy | Poland | 82,7 |
| 2516 | Cord Tissue | Allogeneic – Unrelated | Macular Degeneration | Ophthalmology | 2020 | Experimental Therapy | Poland | 20,8 |
| 2517 | Cord Tissue | Allogeneic – Unrelated | Muscular Dystrophy | Neurology | 2020 | Experimental Therapy | Poland | 56,4 |
| 2518 | Cord Tissue | Allogeneic – Unrelated | Myelomeningocele | Neurology | 2020 | Experimental Therapy | Poland | 8,11 |
| 2519 | Cord Tissue | Allogeneic – Unrelated | Myelomeningocele; Arnold-Chiari Malformation | Neurology | 2020 | Experimental Therapy | Poland | 2,5 |
| 2520 | Cord Tissue | Allogeneic – Unrelated | Myelomeningocele; Hydrocephalus | Neurology | 2020 | Experimental Therapy | Poland | 2,11 |
| 2521 | Cord Tissue | Allogeneic – Unrelated | Myoclonic Epilepsy With Ragged Red Fibers | Neurology | 2020 | Experimental Therapy | Poland | 23,4 |
| 2522 | Cord Tissue | Allogeneic – Unrelated | No Bone Adhesion | Orthopedy | 2020 | Experimental Therapy | Poland | 69,5 |
| 2523 | Cord Tissue | Allogeneic – Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 16,3 |
| 2524 | Cord Tissue | Allogeneic – Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 66,3 |
| 2525 | Cord Tissue | Allogeneic – Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 23,11 |
| 2526 | Cord Tissue | Allogeneic – Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 27,1 |
| 2527 | Cord Tissue | Allogeneic – Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 31,9 |
| 2528 | Cord Tissue | Allogeneic – Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 58,3 |
| 2529 | Cord Tissue | Allogeneic – Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 41,2 |
| 2530 | Cord Tissue | Allogeneic – Unrelated | Optic Neuropathy | Ophthalmology | 2020 | Experimental Therapy | Poland | 41,2 |
| 2531 | Cord Tissue | Allogeneic – Unrelated | Osteoarthritis | Orthopedy | 2020 | Experimental Therapy | Poland | 56,5 |
| 2532 | Cord Tissue | Allogeneic – Unrelated | Other Specific Cartilage Diseases | Orthopedy | 2020 | Experimental Therapy | Poland | 39,4 |
| 2533 | Cord Tissue | Allogeneic – Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2020 | Experimental Therapy | Poland | 4,1 |
| 2534 | Cord Tissue | Allogeneic – Unrelated | Other Specific Disorders Of The Central Nervous System – Global Development Delay And Microcephaly | Neurology | 2020 | Experimental Therapy | Poland | 2,11 |
| 2535 | Cord Tissue | Allogeneic – Unrelated | Other Specific Disorders Of The Central Nervous System; Congenital Genetic Defect | Neurology | 2020 | Experimental Therapy | Poland | 2,6 |
| 2536 | Cord Tissue | Allogeneic – Unrelated | Other Specific Disorders Of The Central Nervous System; Congenital Genetic Defect | Neurology | 2020 | Experimental Therapy | Poland | 5,2 |
| 2537 | Cord Tissue | Allogeneic – Unrelated | Other Specific Disorders Of The Central Nervous System; Cornelia De Lange Syndrome | Neurology | 2020 | Experimental Therapy | Poland | 4,4 |
| 2538 | Cord Tissue | Allogeneic – Unrelated | Other Specific Disorders Of The Central Nervous System; Hypoxia-Ischemic Encephalopathy | Neurology | 2020 | Experimental Therapy | Poland | 4,3 |
| 2539 | Cord Tissue | Allogeneic – Unrelated | Other Specific Disorders Of The Central Nervous System; Lissencephaly | Neurology | 2020 | Experimental Therapy | Poland | 6,4 |
| 2540 | Cord Tissue | Allogeneic – Unrelated | Other Sphingolipidoses; Krabbe's Leukodystrophy | Neurology | 2020 | Experimental Therapy | Poland | 4 |
| 2541 | Cord Tissue | Allogeneic – Unrelated | Other Spinal Muscular Atrophy And Related Syndromes; Bulbar Palsy | Neurology | 2020 | Experimental Therapy | Poland | no data |
| 2542 | Cord Tissue | Allogeneic – Unrelated | Polyneuropathy | Neurology | 2020 | Experimental Therapy | Poland | 43,11 |
| 2543 | Cord Tissue | Allogeneic – Unrelated | Sclerosis Multiplex | Neurology | 2020 | Experimental Therapy | Poland | 33,7 |
| 2544 | Cord Tissue | Allogeneic – Unrelated | Sclerosis Multiplex | Neurology | 2020 | Experimental Therapy | Poland | 61,5 |
| 2545 | Cord Tissue | Allogeneic – Unrelated | Soft Tissue Diseases Related To Use, Overload And Pressure | Orthopedy | 2020 | Experimental Therapy | Poland | 59,6 |
| 2546 | Cord Tissue | Allogeneic – Unrelated | Spina Bifida | Neurology | 2020 | Experimental Therapy | Poland | 11 months |
| 2547 | Cord Tissue | Allogeneic – Unrelated | Spina Bifida | Neurology | 2020 | Experimental Therapy | Poland | 1,3 |
| 2548 | Cord Tissue | Allogeneic – Unrelated | Spinal Cord Injury | Neurology | 2020 | Experimental Therapy | Poland | 33,2 |
| 2549 | Cord Tissue | Allogeneic – Unrelated | Spinocerebellar Ataxia | Neurology | 2020 | Experimental Therapy | Poland | 37,11 |
| 2550 | Cord Tissue | Allogeneic – Unrelated | State After Encephalitis | Neurology | 2020 | Experimental Therapy | Poland | 3,8 |
| 2551 | Cord Tissue | Allogeneic – Unrelated | Tendon Injury | Orthopedy | 2020 | Experimental Therapy | Poland | 29 |
| 2552 | Cord Tissue | Allogeneic – Unrelated | Transplantation Failure; Coexisting Viral Infections | Hematology | 2020 | Experimental Therapy | Poland | 13,1 |
| 2553 | Cord Blood | Autologous | Autism | Neurology | 2020 | Experimental Therapy | Poland | no data |
| 2554 | Cord Blood | Autologous | Autism | Neurology | 2020 | Experimental Therapy | Germany | 9 |
| 2555 | Cord Blood | Autologous | Autism | Neurology | 2020 | Experimental Therapy | Germany | 5 |
| 2556 | Cord Blood | Autologous | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | UK | 5 |
| 2557 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 2,2 |
| 2558 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 2,9 |
| 2559 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 2,4 |
| 2560 | Cord Blood | Allogeneic – Related | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | no data |
| 2561 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2020 | Standard Therapy | Turkey | 3,4 |
| 2562 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2020 | Standard Therapy | Turkey | 3,4 |
| 2563 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2020 | Standard Therapy | Turkey | 4,4 |
| 2564 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2020 | Standard Therapy | Turkey | 4,4 |
| 2565 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia – Relapse | Hematology | 2020 | Standard Therapy | Germany | 57 |
| 2566 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 69 |
| 2567 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 48 |
| 2568 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 2569 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 72 |
| 2570 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 59 |
| 2571 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 38 |
| 2572 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 2573 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 76 |
| 2574 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia – Relapse | Hematology | 2020 | Standard Therapy | Germany | 61 |
| 2575 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia – Relapse | Hematology | 2020 | Standard Therapy | Germany | 68 |
| 2576 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 2577 | Bone Marrow Family | Allogeneic | Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 35 |
| 2578 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 71 |
| 2579 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 31 |
| 2580 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 62 |
| 2581 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 59 |
| 2582 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 67 |
| 2583 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 2584 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 70 |
| 2585 | Bone Marrow Family | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Germany | 24 |
| 2586 | Bone Marrow (Apheresismily donor) | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 68 |
| 2587 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 14 |
| 2588 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 1 |
| 2589 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 52 |
| 2590 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 66 |
| 2591 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 4 |
| 2592 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 15 |
| 2593 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 5 |
| 2594 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 3 |
| 2595 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 62 |
| 2596 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 47 |
| 2597 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 1 |
| 2598 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 16 |
| 2599 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 43 |
| 2600 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 9 |